* Treatment options for UC include medications like 5-aminosalicylates, corticosteroids, and newer biological agents like infliximab and adalimumab, aimed at achieving remission and preventing relapse.
* Recently approved treatments like golimumab and vedolizumab have shown effectiveness for UC, with vedolizumab being a potential first-line alternative for patients not responding to standard therapies.